EIM
IRWD icon

Essex Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Essex Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-41,000
Closed -$657K – 419
2018
Q2 		$657K Buy
+41,000
New +$607K 0.08% 270

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Essex Investment Management's IRWD Position: Q3 2018 in Review

Essex Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2018, closing a stake of 41,000 shares — an estimated $657K sold.

Essex Investment Management first reported a position in IRWD in Q2 2018 and held it in 1 quarter. The position peaked at $657K in Q2 2018. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

  • Essex Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 41,000 Ironwood Pharmaceuticals shares in Q3 2018, an estimated $657K.
  • Essex Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Essex Investment Management's Ironwood Pharmaceuticals position peaked at $657K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.